𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resorbability and solubility of zinc-containing tricalcium phosphate

✍ Scribed by Ito, Atsuo ;Kawamura, Haruo ;Miyakawa, Shunpei ;Layrolle, Pierre ;Kanzaki, Noriko ;Treboux, Gabin ;Onuma, Kazuo ;Tsutsumi, Sadao


Book ID
102292508
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
202 KB
Volume
60
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Using zinc‐containing tricalcium phosphate (ZnTCP) as the zinc carrier for zinc‐releasing calcium phosphate ceramic implants promoted bone formation around the implants. Because no quantitative information was available on the equilibrium solubility and resorbability of ZnTCP, in vitro equilibrium solubility and in vivo resorbability of ZnTCP were determined and compared quantitatively in this study. The solubility of ZnTCP decreased with increasing zinc content. The negative logarithm of the solubility product (K~sp~) of ZnTCP was expressed as p__K__~sp~ = 28.686 + 1.7414__C__ βˆ’ 0.42239__C__^2^ + 0.063911__C__^3^ βˆ’ 0.0051037__C__^4^ + 0.0001595__C__^5^ in air, where C is the zinc content in ZnTCP (mol %). The solubility of ZnTCP containing a nontoxic level of zinc (<0.63 wt %) decreased to 52–92% of the solubility of pure tricalcium phosphate (TCP) in the pH range 5.0–7.4. However, the in vivo resorbed volume of ZnTCP containing the same amount of zinc was much lower than that expected from the in vitro solubility, becoming as low as 26–20% of that of TCP. Cellular resorption of TCP is substantially a process of dissolution in a fluid with an acidic pH that is maintained by the activities of cells. Therefore, the reduction of the resorbability of ZnTCP could be attributable principally to its lowered cellular activation property relative to that associated with pure TCP. Β© 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 224–231, 2002; DOI 10.1002/jbm.10068


πŸ“œ SIMILAR VOLUMES


Inhibitory effect of Zn2+ in zinc-contai
✍ Yasutaka Yamada; Astuo Ito; Hiroko Kojima; Masataka Sakane; Shumpei Miyakawa; To πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 330 KB

## Abstract Long term effect of the growing instability of the bone‐implant interface due to bone resorption at the interface is a problem for the implants, including bioactive ceramics. Zn^2+^‐containing tricalcium phosphate (ZnTCP) is a material which may overcome this problem. The present study

Implanted octacalcium phosphate is more
✍ Kamakura, S. ;Sasano, Y. ;Shimizu, T. ;Hatori, K. ;Suzuki, O. ;Kagayama, M. ;Mot πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 715 KB

## Abstract Our previous studies have suggested that synthetic octacalcium phosphate (OCP) could be resorbed and replaced by newly formed bone if implanted in rat skull defects. We hypothesized that the implanted OCP is more resorbable than other commonly used bone graft substitutes of calcium phos

Solubility of Mg-containing Ξ²-tricalcium
✍ Xia Li; Atsuo Ito; Yu Sogo; Xiupeng Wang; R.Z. LeGeros πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 438 KB

The equilibrium solubility of Mg-containing b-tricalcium phosphate (bMgTCP) with various magnesium contents was determined by immersing bMgTCP powder for 27 months in a CH 3 COOH-CH 3 COONa buffer solution at 25 Β°C under a nitrogen gas atmosphere. The negative logarithm of the solubility product (pK

Calcium level-responsivein-vitro zinc re
✍ Otsuka, Makoto ;Marunaka, Sunao ;Matsuda, Yoshihisa ;Ito, Atsuo ;Layrolle, Pierr πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 412 KB

The in vitro Zn release from tricalcium phosphate containing Zn (ZnTCP; 0.63, 6.17, and 12.05 Zn w/w%) was investigated. The rates of release from ZnTCP powders were measured in 25 mL of simulated body fluid (SBF) containing 10 mg/100mL Ca (SBF/H), 5 mg/100mL Ca (SBF/L), or no Ca (SBF/-) at pH 7.25,

Development of controlled strength-loss
✍ Samar J. Kalita; Robert Fleming; Himesh Bhatt; Brian Schanen; Ratna Chakrabarti πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 989 KB

Controlling the strength-loss rate during biodegradation is a bottleneck in developing viable resorbable ceramic implants. Resorbable betatricalcium phosphate (Ξ²-TCP) bioceramic is known for its excellent biocompatibility. However, it exhibits poor sinterability and poor flexural strength. Here, we